Document Detail

Issues for new antiepilepsy drug development.
MedLine Citation:
PMID:  23406913     Owner:  NLM     Status:  MEDLINE    
PURPOSE OF REVIEW: Preclinical research in epileptology has been very successful in producing effective drugs. Unfortunately, however, seizures are still not adequately controlled in a third of the affected individuals, and comorbidities still impose a major burden on the quality of life. New preclinical and clinical drug development strategies are needed to identify drugs that target these unmet medical needs.
RECENT FINDINGS: Even in recent years, the antiseizure approach based on screenings has contributed to the identification of new drugs. Thus, it should not be abandoned. However, we propose that a radically new approach, specifically designed to tackle the existing gaps in care, should be developed to complement the traditional screening. This new approach will require integrated strategies for preclinical screening and experimental trial design. In this review, we will attempt to address some of the issues that must be resolved to engage this effort. Are there suitable models to tackle the unmet therapeutic needs in epilepsy? Are there ways to de-risk the transition from preclinical to clinical studies? Are there ways to improve the efficiency of clinical trials and to design ad hoc trials for the unmet therapeutic needs?
SUMMARY: Development and validation of a new, integrated strategy for antiepilepsy drug development is needed to identify truly innovative drugs.
Michele Simonato; Jacqueline A French; Aristea S Galanopoulou; Terence J O'Brien
Related Documents :
1804863 - Lack of effect of paracetamol on the pharmacokinetics of indomethacin and paracetamol i...
19703 - Drug impairment reviews: other drugs.
391173 - Drug-resistant and atypical mycobacterial disease. bacteriology and treatment.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Current opinion in neurology     Volume:  26     ISSN:  1473-6551     ISO Abbreviation:  Curr. Opin. Neurol.     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-03-06     Completed Date:  2013-08-22     Revised Date:  2014-04-02    
Medline Journal Info:
Nlm Unique ID:  9319162     Medline TA:  Curr Opin Neurol     Country:  England    
Other Details:
Languages:  eng     Pagination:  195-200     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Clinical Trials as Topic / standards*,  trends
Drug Discovery / standards*,  trends
Epilepsy / drug therapy*
Grant Support

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Surveillance of epilepsy and prevention of epilepsy and its sequelae: lessons from the Institute of ...
Next Document:  Palliative use of non-invasive ventilation in end-of-life patients with solid tumours: a randomised ...